MedCity News May 26, 2022
Since it measures the total amount of circulating DNA (ctDNA) in a patient’s bloodstream using a simple blood draw, ctDNA liquid biopsy tests offers oncologists with an accurate, molecular, real-time cancer detection tool. It also helps to determine cancer staging and can help assess how aggressive the treatment regimen should be.
Since the mid-1980s, rates of colorectal cancer (CRC) have doubled in individuals ages 20 to 39. Just as notorious as the disease itself are the treatments patients must endure to become cancer-free. Case in point: After undergoing surgery to remove a tumor, high-risk stage II CRC patients and all stage III CRC patients are recommended for chemotherapy, a treatment regimen that has been used since the 1940s, along with...
Today's Sponsors
Today's Sponsor